BRCR Medical Center Inc.

Hollywood, Florida 33021

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma (FL), Marginal Zone Lymphoma, Non Hodgkin Lymphoma, Refractory Diffuse Large B-cell Lymphoma, Relapsed Diffuse Large B-cell Lymphoma

Studies at this site

• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early